How do we critically use long-acting muscarinic receptor antagonists and beta-adrenergic receptor agonists monotherapy, or these combination therapies depending on the situation in Japanese patients with COPD?
1982 ◽
Vol 14
(9)
◽
pp. 495-500
◽
1984 ◽
Vol 18
(5)
◽
pp. 773-778
◽
1983 ◽
Vol 15
(6)
◽
pp. 707-713
◽
Keyword(s):
2014 ◽
Vol 5
(2)
◽
pp. 85-98
◽